We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Indivior Plc | LSE:INDV | London | Ordinary Share | GB00BN4HT335 | ORD USD0.50 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.07% | 1,351.00 | 1,351.00 | 1,354.00 | 1,376.00 | 1,344.00 | 1,353.00 | 90,237 | 15:40:09 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 1.09B | 2M | 0.0148 | 916.89 | 1.84B |
Date | Subject | Author | Discuss |
---|---|---|---|
10/4/2019 10:27 | Get in,golden opportunity to grab and put away! | the canadian mounted | |
10/4/2019 10:24 | fraudelent and trying to sell a product are not the same thing | dealy | |
10/4/2019 10:23 | bottomed out | rmart | |
10/4/2019 10:23 | Take your pick from all the big guns that are dumping.When us markets opens it ......could it take another dip ?The sellers need to stop dumping | sunnybeachboy | |
10/4/2019 10:23 | Problem is that hundreds of people died and payout to cover for the lost life can be very very significant | marmar80 | |
10/4/2019 10:22 | In todays cityAm " Indivior has been charged with engaging in a Fradulent marketing scheme to boost prescription of an opioid drug" Get out of this company. UK company in US fraud case will be wiped off. | hjs | |
10/4/2019 10:22 | Crazy thing is that the product in question aids opioid addiction when prescribed correctly, ultimately it is for your physician to determine, there lies the problem, doctors just get paid for offering a product, it was like candy for them, an easy sell, but they should be held responsible! | bookbroker | |
10/4/2019 10:19 | That's net cash figureTotal Cash Balance $924M | alexios1201 | |
10/4/2019 10:19 | they have 800m USD of net cash | dealy | |
10/4/2019 10:16 | From their results 14/2/19:- "The Group carries a provision for investigative and antitrust litigation matters of $438m. Substantially all of the provision relates to the U.S. Department of Justice investigation". Where the cash would come from is a separate matter! | mortimer7 | |
10/4/2019 10:15 | This will surely rise back to 80p | kirk 6 | |
10/4/2019 10:14 | £521M Cash end of Dec71p equivalentEasy 100% | alexios1201 | |
10/4/2019 10:13 | nothing to pay for at least a year. a lot can happen in that time | dealy | |
10/4/2019 10:12 | As GSK found out, how much did the US Advair litigation cost? It was around $3 billion for memory. Which, surprise, surprise, is the amount mentioned this morning. America First, eh. | essentialinvestor | |
10/4/2019 10:11 | Not if it gets fined $1 Billion buywell3 - 23 Nov 2018 - 01:21:03 - 182 of 390 INDIVIOR THE PILL WITH NO CHEERS OR BEERS - INDV What a bunch of tw@ts that took this to 500p in 2018 And that was after the chances of USA legal actions were known Amazing the amount of investors funds that have been squandered Do some still buying thinking that a small company based outside the USA in the UK is going to win a ruling in their favor in American courts ? Averaging down is not a wise thing when the facts are very much V the reality of the situation USA BIG PHARMA is running the show Buyers of this share are taking on the USA BIG PHARMA lobby in the states ... and the FDA and other regulatory USA bodies Who is going to win ? | buywell3 | |
10/4/2019 10:09 | This is massively oversold now | kirk 6 | |
10/4/2019 10:08 | I think US BIG Pharma and their lobby group Wants this company gone all the above funds got this one badly wrong | buywell3 | |
10/4/2019 10:06 | Standard Life Investments Ltd. as of 15 Mar 2019 112.06m 15.35% Scopia Capital Management LP as of 01 Apr 2019 103.17m 14.13% Artemis Investment Management LLP as of 20 Nov 2018 38.57m 5.28% M&G Investment Management Ltd. as of 01 Mar 2019 36.49m 5.00% Merian Global Investors (UK) Ltd. as of 30 Oct 2018 36.34m 4.98% Fidelity Management & Research Co. as of 27 Nov 2018 30.64m 4.20% Massachusetts Financial Services Co. as of 01 Mar 2019 24.74m 3.39% Norges Bank Investment Management as of 01 Mar 2019 20.09m 2.75% FIL Investment Advisors (UK) Ltd. as of 01 Mar 2019 19.01m 2.60% The Vanguard Group, Inc. as of 01 Mar 2019 13.69m 1.88% | buywell3 | |
10/4/2019 10:04 | dealy 10 Apr '19 - 09:57 - 381 of 381 0 0 0 I never understand these damage claims. how can the company be liable for all revenue it has ever earned? THEY DO IT IN AMERICA SUE THE KNICKERS OFF ANYTHING AND EVERYTHING | the grumpy old men | |
10/4/2019 10:03 | Goldman/Scopia for one What I think needs to be answered is if '' an adverse verdict may have a material adverse effect on the Company and its financial position and outlook.'' means that Indivior will be worthless with negative worth ie fines bigger than the company can afford | buywell3 | |
10/4/2019 10:03 | This is a shocker. Hope there are no large holders here. | minerve 2 | |
10/4/2019 09:59 | '' an adverse verdict may have a material adverse effect on the Company and its financial position and outlook.'' and this might take 12 months to sort out 22M now traded | buywell3 | |
10/4/2019 09:57 | I never understand these damage claims. how can the company be liable for all revenue it has ever earned? | dealy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions